Alx oncology to present at the jefferies 2025 global healthcare conference

South san francisco, calif., may 30, 2025 (globe newswire) -- alx oncology holdings inc., ("alx oncology" or the "company") (nasdaq: alxo), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that management will participate in the jefferies 2025 global healthcare conference. details are as follows:
ALXO Ratings Summary
ALXO Quant Ranking